2017
DOI: 10.1016/j.biopsych.2016.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium

Abstract: BackgroundMajor depressive disorder (MDD) is a disabling mood disorder, and despite a known heritable component, a large meta-analysis of genome-wide association studies revealed no replicable genetic risk variants. Given prior evidence of heterogeneity by age at onset in MDD, we tested whether genome-wide significant risk variants for MDD could be identified in cases subdivided by age at onset.MethodsDiscovery case-control genome-wide association studies were performed where cases were stratified using increa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
141
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 177 publications
(155 citation statements)
references
References 57 publications
(74 reference statements)
12
141
2
Order By: Relevance
“…Moreover, research on recurrent cases here is consistent with sampling methods from the previous molecular studies on AO. 27-29 …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, research on recurrent cases here is consistent with sampling methods from the previous molecular studies on AO. 27-29 …”
Section: Methodsmentioning
confidence: 99%
“…A potential implication of this finding is an increased genetic loading for MD in earlier-onset cases. 29 …”
Section: Introductionmentioning
confidence: 99%
“…For example, MDD workgroup has been a part of the PGC since 2007, and now it covers over 100 000 people with depression. The PGC MDD group has published a paper confronting the notably challenges in genetic dissection of MDD and keeps increasing sample size and expanding their studies . The ENIGMA MDD working group includes brain scans of around >5000 MDD patients and >9000 controls from 35 research samples of 14 different countries worldwide.…”
Section: Future Directionsmentioning
confidence: 99%
“…However, it is of note that RPS analyses could potentially identify clinical subtypes or treatment responses in psychiatric patients, including those with BD; for example, early‐onset MDD had a higher polygenic score based on the BD risk. This finding suggests that clinicians should consider that patients with early‐onset MDD may be at risk for development of BD, and it is reasonable in a clinical sense …”
Section: Clinical Implications Based On Gwas Findingsmentioning
confidence: 95%